RNA-editing protein insights could lead to improved treatment for cancer and autoimmune diseases

Rice University researchers uncovered key mechanisms of ADAR1 protein in RNA editing, revealing its role in preventing unnecessary immune responses. Published in Molecular Cell (March 2025), the study's findings have significant therapeutic potential for autoimmune diseases and cancer immunotherapy, potentially leading to new RNA-targeted treatments.

GENE THERAPY RESEARCH